Kendra KL - Search Results

1

A pilot study of bevacizumab and interferon-α2b in ocular melanoma.

Guenterberg KD, Grignol VP, Relekar KV, Varker KA, Chen HX, Kendra KL, Olencki TE, Carson WE 3rd. Guenterberg KD, et al. Among authors: kendra kl. Am J Clin Oncol. 2011 Feb;34(1):87-91. doi: 10.1097/COC.0b013e3181d2ed67. Am J Clin Oncol. 2011. PMID: 20458209 Free PMC article. Clinical Trial.

2

Multiparametric flow cytometric analysis of inter-patient variation in STAT1 phosphorylation following interferon Alfa immunotherapy.

Lesinski GB, Kondadasula SV, Crespin T, Shen L, Kendra K, Walker M, Carson WE 3rd. Lesinski GB, et al. J Natl Cancer Inst. 2004 Sep 1;96(17):1331-42. doi: 10.1093/jnci/djh252. J Natl Cancer Inst. 2004. PMID: 15339971

3

Phase I clinical trial of the immunocytokine EMD 273063 in melanoma patients.

King DM, Albertini MR, Schalch H, Hank JA, Gan J, Surfus J, Mahvi D, Schiller JH, Warner T, Kim K, Eickhoff J, Kendra K, Reisfeld R, Gillies SD, Sondel P. King DM, et al. J Clin Oncol. 2004 Nov 15;22(22):4463-73. doi: 10.1200/JCO.2004.11.035. Epub 2004 Oct 13. J Clin Oncol. 2004. PMID: 15483010 Free PMC article. Clinical Trial.

4

Phase II trial of neoadjuvant chemotherapy with docetaxel followed by epirubicin in stage II/III breast cancer.

Ramaswamy B, Povoski SP, Rhoades C, Allen J, Hauger M, Young D, Burak W, Farrar W, Yee L, Kendra K, Somasundaram S, Orlowski RZ, Shapiro CL. Ramaswamy B, et al. Breast Cancer Res Treat. 2005 Sep;93(1):67-74. doi: 10.1007/s10549-005-3784-z. Breast Cancer Res Treat. 2005. PMID: 16184461 Clinical Trial.

5

Phase II trial of bevacizumab in combination with weekly docetaxel in metastatic breast cancer patients.

Ramaswamy B, Elias AD, Kelbick NT, Dodley A, Morrow M, Hauger M, Allen J, Rhoades C, Kendra K, Chen HX, Eckhardt SG, Shapiro CL. Ramaswamy B, et al. Clin Cancer Res. 2006 May 15;12(10):3124-9. doi: 10.1158/1078-0432.CCR-05-2603. Clin Cancer Res. 2006. PMID: 16707611 Clinical Trial.

6

Phase II study of weekly docetaxel and capecitabine in patients with metastatic breast cancer.

Mrozek E, Ramaswamy B, Young D, Rhoades CA, Kendra K, Allen J, Moore T, Hauger M, Watson H, Merriman N, Nadella P, Villalona-Calero M, Shapiro CL. Mrozek E, et al. Clin Breast Cancer. 2006 Jun;7(2):141-5. doi: 10.3816/CBC.2006.n.023. Clin Breast Cancer. 2006. PMID: 16800973 Clinical Trial.

7

Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy.

Varker KA, Kondadasula SV, Go MR, Lesinski GB, Ghosh-Berkebile R, Lehman A, Monk JP, Olencki T, Kendra K, Carson WE 3rd. Varker KA, et al. Clin Cancer Res. 2006 Oct 1;12(19):5850-8. doi: 10.1158/1078-0432.CCR-06-1159. Clin Cancer Res. 2006. PMID: 17020993

8

A randomized phase 2 trial of bevacizumab with or without daily low-dose interferon alfa-2b in metastatic malignant melanoma.

Varker KA, Biber JE, Kefauver C, Jensen R, Lehman A, Young D, Wu H, Lesinski GB, Kendra K, Chen HX, Walker MJ, Carson WE 3rd. Varker KA, et al. Ann Surg Oncol. 2007 Aug;14(8):2367-76. doi: 10.1245/s10434-007-9389-5. Epub 2007 May 30. Ann Surg Oncol. 2007. PMID: 17534686 Clinical Trial.

9

Activation of extracellular signaling regulated kinase in natural killer cells and monocytes following IL-2 stimulation in vitro and in patients undergoing IL-2 immunotherapy: analysis via dual parameter flow-cytometric assay.

Kondadasula SV, Varker KA, Lesinski GB, Benson DM Jr, Lehman A, Olencki T, Monk JP, Kendra K, Carson WE 3rd. Kondadasula SV, et al. Cancer Immunol Immunother. 2008 Aug;57(8):1137-49. doi: 10.1007/s00262-007-0444-7. Epub 2008 Jan 10. Cancer Immunol Immunother. 2008. PMID: 18193422 Free PMC article.

10

IFN-alpha-2b-induced signal transduction and gene regulation in patient peripheral blood mononuclear cells is not enhanced by a dose increase from 5 to 10 megaunits/m2.

Zimmerer JM, Lehman AM, Ruppert AS, Noble CW, Olencki T, Walker MJ, Kendra K, Carson WE 3rd. Zimmerer JM, et al. Clin Cancer Res. 2008 Mar 1;14(5):1438-45. doi: 10.1158/1078-0432.CCR-07-4178. Clin Cancer Res. 2008. PMID: 18316567

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

96 results

Search Page